Assessing the Impact of Health Information Exchange (HIE) on Healthcare Utilization

NCT ID: NCT01147328

Last Updated: 2018-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

218766 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess usage of the virtual health record (VHR), and determine the effects of this technology on healthcare utilization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

National efforts are underway to support the implementation of technology that enables providers to electronically access and view community-wide clinical information for their patients, which has the potential to improve quality of care and reduce health care costs by providing timely and complete health information at the point of care. However, few empirical studies have been conducted to evaluate the economic effects of this technology. Along with other stakeholders, New York State is funding regional health information organizations (RHIOs) to deploy a virtual health record (VHR), which is technology that enables providers to electronically access community-wide clinical data for patients who have consented to have their clinical data accessed via a web portal. RHIOs bring together multiple stakeholders, including physician practices, hospitals, pharmacies, and laboratories, for the purpose of exchanging clinical information electronically across communities. The investigators will conduct a multi-RHIO retrospective pre-post, cohort study of adult patients who have consented to have their clinical data viewed by their providers using the VHR portal. Examining the effects of electronically accessing clinical data on healthcare utilization across multiple settings and communities can help inform the national health IT initiative that is underway and allow assessment of the economic value of these technologies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Information Technology Health Information Exchange Virtual Health Record Health Care Utilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients who did not have their data accessed in the VHR by a provider within 6 months after they consented will be part of the control group

Virtual Health Record (VHR)

Intervention Type OTHER

Technology that enables providers to electronically access community-wide clinical data for patients who have consented to have their clinical data accessed via a web portal.

2

Patients who had their data accessed in the VHR by a provider within 6 months after they consented will be part of the intervention group

Virtual Health Record (VHR)

Intervention Type OTHER

Technology that enables providers to electronically access community-wide clinical data for patients who have consented to have their clinical data accessed via a web portal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Health Record (VHR)

Technology that enables providers to electronically access community-wide clinical data for patients who have consented to have their clinical data accessed via a web portal.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients that are aged 18 and older who have consented during the year 2009 to allow their provider use of their VHR data and had at least one visit to a healthcare provider that is a VHR user within 6 months after they consented to allow their provider use of their VHR data. (Note: we only wish to include individuals who have had the opportunity for their data to be viewed using the VHR web portal). Providers who are participating in the Regional Health Information Exchange (RHIO).

Exclusion Criteria

* Patients and providers who do not meet the above criteria
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New York State Department of Health

OTHER_GOV

Sponsor Role collaborator

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Kern, MD, MPH

Role: STUDY_CHAIR

Weill Medical College of Cornell University

Yolanda Barron, MS

Role: STUDY_CHAIR

Weill Medical College of Cornell University

Alison Edwards, MStat

Role: STUDY_CHAIR

Weill Medical College of Cornell University

Ranjit Singh, MD, MA, MBA

Role: STUDY_CHAIR

Weill Medical College of Cornell University

Renny Varghese, MPH

Role: STUDY_CHAIR

Weill Medical College of Cornell University

Vaishali Patel, PhD, MPH

Role: PRINCIPAL_INVESTIGATOR

Weill Medical College of Cornell University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HealtheLink

Buffalo, New York, United States

Site Status

Weill Medical College of Cornell University

New York, New York, United States

Site Status

Rochester RHIO

Rochester, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0708160258-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VA Integrated Medication Manager
NCT01787175 COMPLETED NA